IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Q2 2026 Holdings

Filed 2026-08-14 | 7 holdings | $345.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sionna Therapeutics Inc(SION)COM829401108$109.0M2,478,03031.6%
Zenas Biopharma Inc(ZBIO)COM98937L105$99.5M3,919,15928.8%
Immunome Inc(IMNM)COM45257U108$76.6M3,613,79922.2%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$20.0M2,626,9465.8%
Compass Therapeutics Inc(CMPX)COM20454B104$17.1M7,788,1504.9%
Upstream BIO Inc(UPB)COM91678A107$17.0M2,459,7034.9%
Camp4 Therapeutics Corp(CAMP)COM13463J101$6.2M1,425,5411.8%